Al-Shahi R, Warlow C. A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain. 2001;124:1900-1926.
Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65:476-483.
Hemphill JC 3rd, Greenberg SM, Anderson CS, et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke. 2015;46:2032-2060.
Ross J, Al-Shahi Salman R. Interventions for treating brain arteriovenous malformations in adults. Cochrane Database Syst Rev. 2010;(7):CD003436.
1. Brown RD Jr., Wiebers DO, Torner JC, et al. Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: a population-based study of intracranial vascular malformations in Olmsted County, Minnesota. J Neurosurg. 1996;85:29-32.
2. Al-Shahi R, Warlow C. A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain. 2001;124:1900-1926.
3. Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65:476-483.
4. De Oliveira E, Tedeschi H, Raso J. Comprehensive management of arteriovenous malformations. Neurol Res. 1998;20:673-683.
5. Al-Shahi R, Fang JS, Lewis SC, et al. Prevalence of adults with brain arteriovenous malformations: a community based study in Scotland using capture-recapture analysis. J Neurol Neurosurg Psychiatry. 2002;73:547-551.
6. Al-Shahi R, Bhattacharya JJ, Currie DG, et al. Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke. 2003;34:1163-1169.
7. Stapf C, Mast H, Sciacca RR, et al. The New York Islands AVM Study: design, study progress, and initial results. Stroke. 2003;34:e29-e33.
8. Moftakhar P, Hauptman JS, Malkasian D, et al. Cerebral arteriovenous malformations: part 1: cellular and molecular biology. Neurosurg Focus. 2009;26:E10.
9. Moftakhar P, Hauptman JS, Malkasian D, et al. Cerebral arteriovenous malformations: part 2: physiology. Neurosurg Focus. 2009;26:E11.
10. Spetzler RF, Wilson CB, Weinstein P, et al. Normal perfusion pressure breakthrough theory. Clin Neurosurg. 1978;25:651-672.
11. Kader A, Young WL. The effects of intracranial arteriovenous malformations on cerebral hemodynamics. Neurosurg Clin N Am. 1996;7:767-781.
12. HashimotoT, Young WL. Anesthesia related considerations for cerebral arteriovenous malformations. Neurosurg Focus. 2001;11:e5.
13. Mast H, Mohr JP, Osipov A, et al. 'Steal' is an unestablished mechanism for the clinical presentation of cerebral arteriovenous malformations. Stroke. 1995;26:1215-1220.
14. Yokoyama K, Asano Y, Murakawa T, et al. Familial occurrence of arteriovenous malformation of the brain. J Neurosurg. 1991;74:585-589.
15. Faughnan ME, Palda VA, Garcia-Tsao G, et al. International guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. J Med Genet. 2011;48:73-87.
16. Hernesniemi JA, Dashti R, Juvela S, et al. Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery. 2008;63:823-829.
17. Mast H, Young WL, Koennecke HC, et al. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet. 1997;350:1065-1068.
18. Stapf C, Mast H, Sciacca RR, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66:1350-1355.
19. Wedderburn CJ, van Beijnum J, Bhattacharya JJ, et al. Outcome after interventional or conservative management of unruptured brain arteriovenous malformation: a prospective, population-based cohort study. Lancet Neurol. 2008;7:223-230.
20. Kaku DA, Lowenstein DH. Emergence of recreational drug abuse as a major risk factor for stroke in young adults. Ann Intern Med. 1990;113:821-827.
21. McEvoy AW, Kitchen ND, Thomas DG. Intracerebral haemorrhage and drug abuse in young adults. Br J Neurosurg. 2000;14:449-454.
22. Wilkins RH. Natural history of intracranial vascular malformations: a review. Neurosurgery. 1985;16:421-430.
23. Itoyama Y, Uemura S, Ushio Y, et al. Natural course of unoperated intracranial arteriovenous malformations: study of 50 cases. J Neurosurg. 1989;71:805-809.
24. Spetzler RF, Hargraves RW, McCormick PW, et al. Relationship of perfusion pressure and size to risk of hemorrhage from arteriovenous malformations. J Neurosurg. 1992;76:918-923.
25. Arnaout OM, Gross BA, Eddleman CS, et al. Posterior fossa arteriovenous malformations. Neurosurg Focus. 2009;26:E12.
26. Perret G, Nishioka H. An analysis of 545 cases of cranio-cerebral arteriovenous malformations and fistulae reported to the Cooperative Study. J Neurosurg. 1966;25:467-490.
27. Brown RD Jr., Wiebers DO, Forbes GS. Unruptured intracranial aneurysms and arteriovenous malformations: frequency of intracranial hemorrhage and relationship of lesions. J Neurosurg. 1990;73:859-863.
28. Hemphill JC 3rd, Greenberg SM, Anderson CS, et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke. 2015;46:2032-2060.
29. Horton JC, Chambers WA, Lyons SL, et al. Pregnancy and the risk of hemorrhage from cerebral arteriovenous malformations. Neurosurgery. 1990;27:867-871.
30. Forster DM, Kunkler IH, Hartland P. Risk of cerebral bleeding from arteriovenous malformations in pregnancy: the Sheffield experience. Stereotact Funct Neurosurg. 1993;61(suppl 1):20-22.
31. Morgenstern LB, Hemphill JC 3rd, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108-2129.
32. Toffol GJ, Biller J, Adams HP Jr. Nontraumatic intracerebral hemorrhage in young adults. Arch Neurol. 1987;44:483-485.
33. Ondra SL, Troupp H, George ED, et al. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up. J Neurosurg. 1990;73:387-391.
34. Kim H, Sidney S, McCulloch CE, et al. Racial/ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke. 2007;38:2430-2437.
35. Ferro JM. Update on intracerebral haemorrhage. J Neurol. 2006;253:985-999.
36. Heros RC, Korosue K, Diebold PM. Surgical excision of cerebral arteriovenous malformations: late results. Neurosurgery. 1990;26:570-577.
37. Osborn AG, ed. Diagnostic neuroradiology. St Louis, MO: Mosby; 1994.
38. Riina HA, Gobin YP. Grading and surgical planning for intracranial arteriovenous malformations. Neurosurg Focus. 2001;11:e3.
39. Andreou A, Ioannidis I, Lalloo S, et al. Endovascular treatment of intracranial microarteriovenous malformations. J Neurosurg. 2008;109:1091-1097.
40. Zhu XL, Chan MS, Poon WS. Spontaneous intracranial hemorrhage: which patients need diagnostic cerebral angiography? A prospective study of 206 cases and review of the literature. Stroke. 1997;28:1406-1409.
41. Chandran A, Radon M, Biswas S, et al. Novel use of 4D-CTA in imaging of intranidal aneurysms in an acutely ruptured arteriovenous malformation: is this the way forward? J Neurointerv Surg. 2016;8:e36.
42. Bambakidis NC, Sunshine JL, Faulhaber PF, et al. Functional evaluation of arteriovenous malformations. Neurosurg Focus. 2001;11:e2.
43. Lazar RM, Marshall RS, Pile-Spellman J, et al. Anterior translocation of language in patients with left cerebral arteriovenous malformation. Neurology. 1997;49:802-808.
44. Lazar RM. Neuropsychological function and brain arteriovenous malformations: redefining eloquence as a risk for treatment. Neurosurg Focus. 2001;11:e4.
45. Willinsky RA, Taylor SM, TerBrugge K, et al. Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology. 2003;227:522-528.
46. Cloft HJ, Joseph GJ, Dion JE. Risk of cerebral angiography in patients with subarachnoid hemorrhage, cerebral aneurysm, and arteriovenous malformation: a meta-analysis. Stroke. 1999;30:317-320.
47. van Rooij WJ, Sluzewski M, Beute GN. Brain AVM embolization with Onyx. AJNR Am J Neuroradiol. 2007;28:172-177.
48. Douglas JG, Goodkin R. Treatment of arteriovenous malformations using gamma knife surgery: the experience at the University of Washington from 2000 to 2005. J Neurosurg. 2008;109(suppl):51-56.
49. Sirin S, Kondziolka D, Niranjan A, et al. Prospective staged volume radiosurgery for large arteriovenous malformations: indications and outcomes in otherwise untreatable patients. Neurosurgery. 2008;62(suppl 2):744-754.
50. Mohr JP, Parides MK, Stapf C, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383:614-621.
51. Guo Y, Saunders T, Su H, et al; University of California, San Francisco Brain Arteriovenous Malformation (UCSF bAVM) Study Project. Silent intralesional microhemorrhage as a risk factor for brain arteriovenous malformation rupture. Stroke. 2012;43:1240-1246.
52. Abla AA, Nelson J, Kim H, et al. Silent arteriovenous malformation hemorrhage and the recognition of "unruptured" arteriovenous malformation patients who benefit from surgical intervention. Neurosurgery. 2015;76:592-600.
53. Choi JH, Mast H, Sciacca RR, et al. Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke. 2006;37:1243-1247.
54. Hartmann A, Mast H, Mohr JP, et al. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke. 1998;29:931-934.
55. Ross J, Al-Shahi Salman R. Interventions for treating brain arteriovenous malformations in adults. Cochrane Database Syst Rev. 2010;(7):CD003436.
56. Perrini P, Scollato A, Cellerini M, et al. Results of surgical and endovascular treatment of intracranial micro-arteriovenous malformations with emphasis on superselective angiography. Acta Neurochir (Wien). 2004;146:755-766.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台